Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Neuropharmacology

• Publication date

  1984-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0028-3908(84)90100-XPMID 6084823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.

  1984cited by this paper
• Suicide and serotonin receptors.

  1984cited by this paper
• Serotonin Receptor Changes in Dementia of the Alzheimer Type

  1984cited by this paper
• Decreased Imipramine Binding in the Brains of Patients with Depressive Illness

  1983cited by this paper
• Increased serotonin-2 binding sites in frontal cortex of suicide victims.

  1983cited by this paper
• Neuropeptides in Alzheimer type dementia.

  1983cited by this paper
• Retrograde cell degeneration in the basal nucleus in monkey and man.

  1983cited by this paper
• Monoamine metabolism in senile dementia of Alzheimer type.

  1983cited by this paper
• Serotonin nerve cells in Alzheimer's disease.

  1983cited by this paper
• Cortical muscarinic receptor subtypes and Alzheimer's disease.

  1982cited by this paper
• Interactions of [3H]LSD with serotonin receptors in human brain.

  1982cited by this paper
• Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

  1982cited by this paper
• Human brain receptor alterations in suicide victims.

  1982cited by this paper
• Alzheimer's disease as a disorder of isodendritic core.

  1982cited by this paper
• Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia

  1982cited by this paper
• Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

  1982cited by this paper
• The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.

  1982cited by this paper
• The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection.

  1981cited by this paper
• A quantitative study of cerebral atrophy in old age and senile dementia.

  1981cited by this paper
• Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia.

  1981cited by this paper
• Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease

  1981cited by this paper
• VI. The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection

  1981cited by this paper
• Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

  1980cited by this paper
• 4‐HYDROXY‐3‐METHOXYPHENYLGLYCOL AS AN INDEX OF BRAIN NORADRENALINE TURNOVER IN ENDOGENOUS DEPRESSION

  1980cited by this paper
• Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type

  1979cited by this paper
• Accelerated ageing or selective neuronal loss as an important cause of dementia?

  1979cited by this paper
• THE LOCUS CAERULEUS IN ALZHETMERʼS DISEASE

  1978cited by this paper
• Benzodiazepine receptors in rat brain

  1977cited by this paper
• Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.

  1977cited by this paper
• Necropsy evidence of central cholinergic deficits in senile dementia.

  1977cited by this paper
• Regional serotonin levels in brain: a comparison of depressive suicides and alcoholic suicides with controls.

  1976cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

  1976cited by this paper
• Regional distribution of norepinephrine and dopamine in brains of depressive suicides and alcoholic suicides.

  1975cited by this paper
• Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients.

  1974cited by this paper
• The role of dopamine in depression.

  1973cited by this paper
• 5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

  1969cited by this paper
• Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

  1968cited by this paper
• Observations on the brains of demented old people.

  1968cited by this paper
• Biogenic Amines and Emotion

  1967cited by this paper
• The Biochemistry of Affective Disorders

  1967cited by this paper
• 5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

  1967cited by this paper
• Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia

  1966cited by this paper
• Alzheimer's neurofibrillary changes. A topographic study.

  1962cited by this paper
• Effect of Reserpine on the Storage of Catechol Amines in Brain and Other Tissues

  1961cited by this paper
• Depressive states during Rauwolfia therapy for arterial hypertension; a report of 30 cases.

  1956cited by this paper
• DEPRESSION BY RESERPINE OF THE NORADRENALINE CONCENTRATION IN THE HYPOTHALAMUS OF THE CAT

  1956cited by this paper
• Serotonin as a mediator of reserpine action in brain.

  1956cited by this paper
• Depression and anxiety occurring during Rauwolfia therapy.

  1955cited by this paper
• Hypertension treated with Rauwolfia serpentina (whole root) and with reserpine; controlled study disclosing occasional severe depression.

  1955cited by this paper
• Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

  1954cited by this paper

• Weevil Smelling Like a Moth: Bombykyl Acetate as the Aggregation-Sex Pheromone of the Brazilian Vanilla Pest, Montella sp. (Coleoptera: Curculionidae)

  2025cites this paper
• Cortical 5-HT2A receptors in depression and suicide: a systematic review and meta-analysis of in vivo and post-mortem imaging studies

  2025cites this paper
• Recent Progress in Biosensors for Depression Monitoring—Advancing Personalized Treatment

  2024cites this paper
• Alzheimer's Disease and Suicide: An Integrative Literature Review.

  2024cites this paper
• Putative pathological mechanisms of late-life depression and Alzheimer's Disease.

  2023cites this paper
• Decreased 5‐HT1A binding in mild Alzheimer's disease—A positron emission tomography study

  2022cites this paper
• Hyperhomocysteinemia alters cytokine gene expression, cytochrome c oxidase activity and oxidative stress in striatum and cerebellum of rodents.

  2021cites this paper
• Mechanisms of Psychiatric Comorbidities in Epilepsy.

  2021cites this paper
• Relationship between elevated impulsivity and cognitive declines in elderly community-dwelling individuals

  2020cites this paper
• Dementia-related psychosis and the potential role for pimavanserin

  2020cites this paper
• Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease.

  2019cites this paper
• Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment

  2018cites this paper
• OBscure but not OBsolete: Perturbations of the frontal cortex in common between rodent olfactory bulbectomy model and major depression.

  2018cites this paper
• Neurobiology of Suicidal Behaviour

  2018cites this paper
• Targeting the NMDA receptor/NO signalling pathway following L-α aminoadipic acid-induced astrocytic impairment and associated changes in the structural plasticity of neurons

  2018cites this paper
• Recent Advances in Translational Magnetic Resonance Imaging in Animal Models of Stress and Depression

  2017cites this paper
• Neurobiology of Elderly Suicide

  2016cites this paper
• Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT

  2016cites this paper
• Evaluation du traitement visuel précoce des visages chez les usagers de cannabis : étude par potentiels évoqués

  2016cites this paper
• Les modifications neurochimiques pathologiques qui surviennent dans le cerveau lors du vieillissement et au cours des démences

  2016cites this paper
• A pathological investigation of the frontal lobe in post-stroke dementia and other ageing-related dementias

  2015cites this paper
• Brain Serotonin 2 Receptors in Major Depression

  2015cites this paper
• Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties

  2015cites this paper
• 4 – Approches pharmacologique et physiopathologique de la dépression majeure : un aller-retour paradigmatique

  2015cites this paper
• Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.

  2014cites this paper
• Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine.

  2014influential citation
• Elevated serotonin and 5‐HIAA in the brainstem and lower serotonin turnover in the prefrontal cortex of suicides

  2014cites this paper
• Comparison of Sertraline, Venlafaxine and Desipramine Effects on Depression, Cognition and the Daily Living Activities in Alzheimer Patients

  2014cites this paper
• The neurobiology of suicide - A Review of post-mortem studies

  2013cites this paper
• Neurochemical imaging and depressive behaviours.

  2013cites this paper
• Serotonin (5-HT) in the regulation of depression-related emotionality: insight from 5-HT transporter and tryptophan hydroxylase-2 knockout mouse models.

  2013cites this paper
• Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.

  2013cites this paper
• Biological basis of suicide and suicidal behavior

  2013cites this paper
• The serotonergic system in ageing and Alzheimer's disease.

  2012cites this paper
• Neuroanatomy of Serotonergic Abnormalities in Suicide

  2012cites this paper
• Peripheral Biomarkers for Suicide

  2012cites this paper
• Altered serotonergic neurotransmission as a main player in the pathophysiology of Alzheimer's disease : structural and ultrastructural studies in a triple transgenic mouse model of the disease

  2012cites this paper
• β‐Amyloid induced effects on cholinergic, serotonergic, and dopaminergic neurons is differentially counteracted by anti‐inflammatory drugs

  2012cites this paper
• Noradrenergic Dysfunction in Depression and Suicide

  2012cites this paper
• Neuroimaging High Risk States for Suicide

  2012cites this paper
• An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease

  2011cites this paper
• Neural Foundations of Major Depression: Classical Approaches and New Frontiers

  2011cites this paper
• Genetic Regulation of Emotion Brain Circuitries

  2011cites this paper
• Factorii biologici care favorizează efectuarea acţiunilor autoagresive şi a suicidul realizat

  2011cites this paper
• Major depression, cognitive dysfunction and Alzheimer's disease: is there a link?

  2010cites this paper
• Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?

  2010cites this paper
• What can post-mortem studies tell us about the pathoetiology of suicide?

  2010cites this paper
• Suicide neurobiology.

  2009cites this paper
• Norepinephrine Homogeneously Inhibits α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate- (AMPAR-) Mediated Currents in All Layers of the Temporal Cortex of the Rat

  2009cites this paper
• Peripheral Biological Markers for Mood Disorders

  2009cites this paper
• Applying neuroimaging ligands to study major depressive disorder.

  2008cites this paper
• Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.

  2008influential citation
• Stress, genes and the biology of suicidal behavior.

  2008cites this paper
• Socio‐psychological factors in suicide with Alzheimer’s disease: comparative case studies of two patients in the USA and Japan

  2007cites this paper
• A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease.

  2007cites this paper
• Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.

  2007cites this paper
• The role of dopamine in the pathophysiology of depression.

  2007cites this paper
• Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride.

  2007cites this paper
• Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.

  2007cites this paper
• Serotonergic Dysfunction in Mood Disorders

  2007cites this paper
• Platelet 5-HT2A receptor subresponsivity and lethality of attempted suicide in depressed in-patients.

  2007influential citation
• Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.

  2006cites this paper
• A study of the serotonin transporter in the prefrontal cortex in late‐life depression and Alzheimer's disease with and without depression

  2006cites this paper
• Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide.

  2006cites this paper
• Neuroimaging of the Serotonin Transporter: Possibilities and Pitfalls.

  2006cites this paper
• Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters.

  2006cites this paper
• PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.

  2006cites this paper
• Lower3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites

  2005cites this paper
• A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation

  2005cites this paper
• Increasedα 2;-adrenoceptor density in the frontal cortex of depressed suicide victims

  2005cites this paper
• DEPRESIÓN Y RIESGO DE SUICIDIO: POSIBLES INDICADORES BIOQUÍMICOS EN PACIENTES PSIQUIÁTRICOS CON INTENTO DE SUICIDIO EN EL SURESTE DE MÉXICO

  2005cites this paper
• Suicide : autopsie psychologique, outil de recherche en prévention

  2005cites this paper
• Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity

  2005cites this paper
• Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors

  2005cites this paper
• Depression and suicide risk : Possible biochemical indicators in psychiatric patients that attempted suicide from Southeast of Mexico

  2005cites this paper
• The Biology and Genetics of Suicidality

  2005cites this paper
• Brain 5-HT1 binding sites in depressed suicides

  2005cites this paper
• The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

  2005cites this paper
• Theories on Mechanism of Action of Electroconvulsive Therapy

  2005cites this paper
• Association of the −141C Del variant of the dopamine D2 receptor (DRD2) with positive family history and suicidality in German alcoholics

  2005cites this paper
• MHPG excretion in endogenous depression: Relationship to clinical state and the effects of ECT

  2004cites this paper
• Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease

  2004cites this paper
• Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography.

  2004cites this paper
• Functional neurochemistry of Alzheimer's disease.

  2004cites this paper
• Modifications of serotonergic and adrenergic receptor concentrations in the brain of aggressive Canis familiaris.

  2004cites this paper
• Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

  2004cites this paper
• Stress Impairs α1A Adrenoceptor-Mediated Noradrenergic Facilitation of GABAergic Transmission in the Basolateral Amygdala

  2004cites this paper
• Decreased Hippocampal 5-HT2A Receptor Binding in Older Depressed Patients Using [18F]Altanserin Positron Emission Tomography

  2004cites this paper
• Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

  2004cites this paper
• PET imaging of beta-adrenoceptors in human brain: a realistic goal or a mirage?

  2004cites this paper
• Serotonergic and noradrenergic neurobiology of alcoholic suicide.

  2004cites this paper
• Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings.

  2003cites this paper
• Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression.

  2003cites this paper
• Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT.

  2003cites this paper
• Effects of β-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat

  2003cites this paper
• [3H]-ketanserin binding sites in different psychiatric disorders.

  2003cites this paper
• Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter.

  2003cites this paper
• Functional neuroinflammatory- and serotonergic imaging in Alzheimer's disease: validation and preliminary clinical findings

  2003cites this paper
• Serotonin Transporter: A Potential Substrate in the Biology of Suicide

  2003cites this paper
• Neurobiology of suicidal behaviour

  2003cites this paper